Bank of Montreal Can raised its holdings in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 0.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,708,937 shares of the medical technology company’s stock after buying an additional 7,886 shares during the period. Bank of Montreal Can owned about 2.57% of Hill-Rom worth $161,325,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in HRC. Vigilant Capital Management LLC purchased a new position in shares of Hill-Rom during the second quarter valued at approximately $109,000. Point72 Asia Hong Kong Ltd boosted its position in shares of Hill-Rom by 1,978.1% during the first quarter. Point72 Asia Hong Kong Ltd now owns 1,330 shares of the medical technology company’s stock valued at $116,000 after buying an additional 1,266 shares during the period. Flagship Harbor Advisors LLC purchased a new position in shares of Hill-Rom during the second quarter valued at approximately $173,000. CIBC Asset Management Inc purchased a new position in shares of Hill-Rom during the second quarter valued at approximately $203,000. Finally, Hartford Investment Management Co. purchased a new position in shares of Hill-Rom during the second quarter valued at approximately $215,000. Institutional investors and hedge funds own 84.83% of the company’s stock.

Shares of NYSE HRC opened at $88.21 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.58 and a debt-to-equity ratio of 1.24. The company has a market capitalization of $6.27 billion, a P/E ratio of 22.77, a PEG ratio of 1.47 and a beta of 0.89. Hill-Rom Holdings, Inc. has a 52-week low of $75.21 and a 52-week high of $98.96.

Hill-Rom (NYSE:HRC) last announced its quarterly earnings results on Friday, July 27th. The medical technology company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.13 by $0.02. The firm had revenue of $708.60 million during the quarter, compared to analyst estimates of $707.50 million. Hill-Rom had a return on equity of 20.54% and a net margin of 8.19%. Hill-Rom’s quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.91 earnings per share. Analysts anticipate that Hill-Rom Holdings, Inc. will post 4.64 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, September 28th. Investors of record on Friday, September 21st were issued a $0.20 dividend. The ex-dividend date of this dividend was Thursday, September 20th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.91%. Hill-Rom’s payout ratio is 20.73%.

Several brokerages have issued reports on HRC. Morgan Stanley boosted their target price on Hill-Rom from $95.00 to $100.00 and gave the company an “equal weight” rating in a research report on Thursday. KeyCorp boosted their target price on Hill-Rom from $97.00 to $115.00 and gave the company an “overweight” rating in a research report on Tuesday, July 17th. Raymond James boosted their target price on Hill-Rom from $97.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, July 30th. Zacks Investment Research upgraded Hill-Rom from a “hold” rating to a “buy” rating and set a $98.00 price target for the company in a report on Monday, July 2nd. Finally, ValuEngine lowered Hill-Rom from a “buy” rating to a “hold” rating in a report on Saturday, June 16th. Five analysts have rated the stock with a hold rating and six have given a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $100.00.

About Hill-Rom

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Further Reading: Understanding Average Daily Trade Volume

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.